Skip to main content
Equibles
SANA logo

SANA · Sana Biotechnology, Inc. · Investor Relations

Track SANA — free

Use SANA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SANA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.41 +0.11 (+4.77%)
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$688.53M
Shares
299.36M
Volume · Oct 20 3.48M Avg daily vol (3M) 3.2M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Key facts CIK 1770121 CUSIP 799566104 13F (30d) 14 filings 14 filers Visit website Investor relations